{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:24:46Z","timestamp":1787102686918,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antimicrobial resistance is a growing global threat driven by inappropriate antimicrobial use. The Four Moments of Antibiotic Decision Making is a stewardship framework that promotes rational antibiotic use. This study applied this framework to audit antimicrobial prescribing, assess adherence, and measure antimicrobial use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, cross-sectional audit of patients who received systemic antimicrobials between October and November 2023. The four audited moments included: (1) indication, suspected site, and clinical evidence of infection; (2) antimicrobial selection and culture collection; (3) reassessment between days 3 and 5 based on clinical response and culture results; and (4) treatment duration. Antimicrobial consumption was measured using days of therapy (DOT), length of therapy (LOT) and the WHO AWaRe classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 228 patients (53.5% male; mean age 57\u00a0years) received 304 antimicrobial treatments, including 129 intensive care units (ICU) admissions. 75.0% were fully adherent to all Four Moments. Adherence rates across moments 1 to 4 were 97%, 88.8%, 89.3%, and 87.1%, respectively. In moment 2, cultures were indicated in 201 treatments but not requested in 15% of cases. Vancomycin was the most prolonged treatment, followed by ceftriaxone, piperacillin-tazobactam, and meropenem. Antimicrobial use was higher in ICUs, with DOT and LOT reaching 739 and 706 per 1,000 patient-days, respectively, compared with 496 and 319 in the wards. Most antimicrobial consumption corresponded to WHO AWaRe Watch antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adherence to stewardship principles was high, although opportunities for improvement remain, particularly regarding culture collection and treatment duration optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-026-01761-4","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:53:58Z","timestamp":1781258038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Audit of the prescription of antimicrobials using the four moments of decision tool in a university hospital"],"prefix":"10.1186","volume":"15","author":[{"given":"Amanda Magalh\u00e3es Vilas Boas","family":"Cambiais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanusa Barbosa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a Cassia Pereira","family":"Sforsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Marcelo Sa","family":"Malbouisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"De Luccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleia Faustina","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdcaro","family":"Boszczowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Figueiredo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"1761_CR1","unstructured":"CDC. The Core Elements of Hospital Antibiotic Stewardship Programs. Published online 2014. Accessed December 14, 2022. https:\/\/www.cdc.gov\/antibiotic-use\/healthcare\/pdfs\/core-elements.pdf"},{"key":"1761_CR2","unstructured":"O\u2019Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Government of the United Kingdom; 2016. Accessed December 29, 2022. https:\/\/apo.org.au\/node\/63983"},{"key":"1761_CR3","unstructured":"CDC. Antibiotic Resistance. August 8, 2022. Accessed December 14, 2022. https:\/\/www.cdc.gov\/drugresistance\/index.html"},{"key":"1761_CR4","unstructured":"CDC Centers for Disease Control and Prevention C. Core Elements of Hospital Antibiotic Stewardship Programs | Antibiotic Use |. 2021. Accessed December 15, 2022. https:\/\/www.cdc.gov\/antibiotic-use\/core-elements\/hospital.html"},{"issue":"11","key":"1761_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1310\/hpj5011-1011","volume":"50","author":"CJ Graber","year":"2015","unstructured":"Graber CJ, Jones MM, Glassman PA, et al. Taking an antibiotic time-out: utilization and usability of a self-stewardship time-out program for renewal of Vancomycin and Piperacillin-Tazobactam. Hosp Pharm. 2015;50(11):1011\u201324. https:\/\/doi.org\/10.1310\/hpj5011-1011.","journal-title":"Hosp Pharm"},{"issue":"9","key":"1761_CR6","first-page":"194","volume":"63","author":"S Fridkin","year":"2014","unstructured":"Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194\u2013200.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1761_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases society of america and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159\u201377. https:\/\/doi.org\/10.1086\/510393.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1761_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/antibiotics10091078","volume":"10","author":"SM Mohayya","year":"2021","unstructured":"Mohayya SM, Narayanan N, Cimilluca D, Malanowski A, Vaidya P, Bhowmick T. Effectiveness of an electronic automated antibiotic time out alert in the setting of gram-negative bacteremia. Antibiotics Basel. 2021;10(9):1078. https:\/\/doi.org\/10.3390\/antibiotics10091078.","journal-title":"Antibiotics Basel"},{"key":"1761_CR9","unstructured":"Agency for Healthcare Research and Quality. Four Moments of Antibiotic Decision Making. Accessed November 30, 2022. https:\/\/www.ahrq.gov\/antibiotic-use\/acute-care\/four-moments\/index.html"},{"issue":"9","key":"1761_CR10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/antibiotics11091226","volume":"11","author":"AF Campos","year":"2022","unstructured":"Campos AF, Arantes T, Cambiais AMVB, et al. Impact of an antimicrobial stewardship program intervention associated with the rapid identification of microorganisms by MALDI-TOF and detection of resistance genes in ICU patients with Gram-Negative bacteremia. Antibiotics Basel. 2022;11(9):1226. https:\/\/doi.org\/10.3390\/antibiotics11091226.","journal-title":"Antibiotics Basel"},{"key":"1761_CR11","doi-asserted-by":"publisher","DOI":"10.7326\/M13-3016","author":"CT Lee","year":"2014","unstructured":"Lee CT, Frenette C, Jayaraman D, Green L, Pilote L. Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use. Ann Intern Med. 2014. https:\/\/doi.org\/10.7326\/M13-3016.","journal-title":"Ann Intern Med"},{"issue":"11","key":"1761_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1017\/ice.2019.197","volume":"40","author":"JR Wolfe","year":"2019","unstructured":"Wolfe JR, Bryant AM, Khoury JA. Impact of an automated antibiotic time-out alert on the de-escalation of broad-spectrum antibiotics at a large community teaching hospital. Infect Control Hosp Epidemiol. 2019;40(11):1287\u20139. https:\/\/doi.org\/10.1017\/ice.2019.197.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"1761_CR13","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/cid\/ciy852","volume":"68","author":"KA Thom","year":"2019","unstructured":"Thom KA, Tamma PD, Harris AD, et al. Impact of a prescriber-driven antibiotic time-out on antibiotic use in hospitalized patients. Clin Infect Dis. 2019;68(9):1581\u20134. https:\/\/doi.org\/10.1093\/cid\/ciy852.","journal-title":"Clin Infect Dis"},{"key":"1761_CR14","unstructured":"Levin ASS, et al. Guia de utiliza\u00e7\u00e3o de anti-infecciosos e recomenda\u00e7\u00f5es para a preven\u00e7\u00e3o de infec\u00e7\u00f5es relacionadas \u00e0 assist\u00eancia \u00e0 sa\u00fade. Editora dos Editores; 2022."},{"key":"1761_CR15","unstructured":"Secretaria de Estado da Sa\u00fade de S\u00e3o Paulo, Centro de Vigil\u00e2ncia Epidemiol\u00f3gica - Divis\u00e3o De Infec\u00e7\u00e3o Hospitalar, DIVIS\u00c3O DE INFEC\u00c7\u00c3O HOSPITALAR. Manual de Orienta\u00e7\u00f5es e Crit\u00e9rios Diagn\u00f3sticos - Defini\u00e7\u00f5es e Conceitos. 2024. Accessed January 4, 2025. https:\/\/www.saude.sp.gov.br\/resources\/cve-centro-de-vigilancia-epidemiologica\/areas-de-vigilancia\/infeccao-hospitalar\/2024\/definicoes_conceitos_2024.pdf"},{"key":"1761_CR16","unstructured":"Instituto Latino Americano de Sepse. Implementa\u00e7\u00e3o de Protocolo Gerenciado de Sepse - Protocolo Cl\u00ednico - Atendimento ao paciente adulto com sepse \/ choque s\u00e9ptico. Published online 2018. Accessed January 4, 2025. https:\/\/ilas.org.br\/wp-content\/uploads\/2022\/02\/protocolo-de-tratamento.pdf"},{"key":"1761_CR17","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.4322\/2179-443X.0735","volume":"42","author":"MC Ricieri","year":"2021","unstructured":"Ricieri MC, GommBarreto HA, Pasquini-Netto H, et al. PRAT tool: a harmonization of antimicrobial stewardship program interventions. Rev Cienc Farm Basica Apl. 2021;42:e735. https:\/\/doi.org\/10.4322\/2179-443X.0735.","journal-title":"Rev Cienc Farm Basica Apl"},{"key":"1761_CR18","unstructured":"ANVISA. Diretriz Nacional para Elabora\u00e7\u00e3o de Programa de Gerenciamento do Uso de Antimicrobianos em Servi\u00e7os de Sa\u00fade.pdf \u2014 Portugu\u00eas (Brasil). Accessed December 27, 2022. https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/servicosdesaude\/publicacoes\/diretriz-nacional-para-elaboracao-de-programa-de-gerenciamento-do-uso-de-antimicrobianos-em-servicos-de-saude.pdf\/view"},{"key":"1761_CR19","unstructured":"World Health Organization. The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book. 1st ed. World Health Organization; 2022."},{"issue":"1","key":"1761_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12879-015-0992-y","volume":"15","author":"E Casaroto","year":"2015","unstructured":"Casaroto E, Marra AR, Camargo TZS, et al. Agreement on the prescription of antimicrobial drugs. BMC Infect Dis. 2015;15(1):248. https:\/\/doi.org\/10.1186\/s12879-015-0992-y.","journal-title":"BMC Infect Dis"},{"key":"1761_CR21","unstructured":"ANVISA M. Power BI Report - Resultados da Avalia\u00e7\u00e3o Nacional dos programas de gerenciamento de antimicrobianos em Hospitais. 2022. Accessed January 26, 2025. https:\/\/app.powerbi.com\/view?r=eyJrIjoiN2E2NjMzZjUtOTU4NC00NTNiLWEzOWQtOTVlMzNkZDJiZmE3IiwidCI6ImI2N2FmMjNmLWMzZjMtNGQzNS04MGM3LWI3MDg1ZjVlZGQ4MSJ9"},{"issue":"12","key":"1761_CR22","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1017\/ice.2023.156","volume":"44","author":"TSN Ku","year":"2023","unstructured":"Ku TSN, Al Mohajer M, Newton JA, et al. Improving antimicrobial use through better diagnosis: the relationship between diagnostic stewardship and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2023;44(12):1901\u20138. https:\/\/doi.org\/10.1017\/ice.2023.156.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"1761_CR23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy381","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American Society for Microbiologya. Clin Infect Dis. 2018;67(6):e1\u201394. https:\/\/doi.org\/10.1093\/cid\/ciy381.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1761_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.7326\/M19-1696","volume":"171","author":"MP Cheng","year":"2019","unstructured":"Cheng MP, Stenstrom R, Paquette K, et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med. 2019;171(8):547. https:\/\/doi.org\/10.7326\/M19-1696.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1761_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.2042-7174.2011.00176.x","volume":"20","author":"CL Candeloro","year":"2018","unstructured":"Candeloro CL, Kelly LM, Bohdanowicz E, Martin CM, Bombassaro AM. Antimicrobial use in a critical care unit: a prospective observational study. Int J Pharm Pract. 2018;20(3):164\u201371. https:\/\/doi.org\/10.1111\/j.2042-7174.2011.00176.x.","journal-title":"Int J Pharm Pract"},{"key":"1761_CR26","doi-asserted-by":"publisher","unstructured":"BALANCE Investigators,. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections. N Engl J Med. Published online November 20, 2024:NEJMoa2404991. https:\/\/doi.org\/10.1056\/NEJMoa2404991","DOI":"10.1056\/NEJMoa2404991"},{"issue":"9","key":"1761_CR27","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308. https:\/\/doi.org\/10.1001\/jamainternmed.2017.1938.","journal-title":"JAMA Intern Med"},{"key":"1761_CR28","doi-asserted-by":"publisher","unstructured":"Clostridioides difficile infection: an update. Infez Med. 2024;32(3). https:\/\/doi.org\/10.53854\/liim-3203-3","DOI":"10.53854\/liim-3203-3"},{"issue":"19","key":"1761_CR29","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588. https:\/\/doi.org\/10.1001\/jama.290.19.2588.","journal-title":"JAMA"},{"issue":"21","key":"1761_CR30","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","volume":"372","author":"RG Sawyer","year":"2015","unstructured":"Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372(21):1996\u20132005. https:\/\/doi.org\/10.1056\/NEJMoa1411162.","journal-title":"N Engl J Med"},{"issue":"9840","key":"1761_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","volume":"380","author":"T Sandberg","year":"2012","unstructured":"Sandberg T, Skoog G, Hermansson AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012;380(9840):484\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(12)60608-4.","journal-title":"Lancet"},{"issue":"15","key":"1761_CR32","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","volume":"164","author":"MJ Hepburn","year":"2004","unstructured":"Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164(15):1669. https:\/\/doi.org\/10.1001\/archinte.164.15.1669.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1761_CR33","doi-asserted-by":"publisher","first-page":"e13874","DOI":"10.1111\/tid.13874","volume":"24","author":"APM Porto","year":"2022","unstructured":"Porto APM, Tavares BDM, De Assis DB, et al. Brazilian perspective: antimicrobial stewardship in solid organ transplant. Transplant Infect Dis. 2022;24(5):e13874. https:\/\/doi.org\/10.1111\/tid.13874.","journal-title":"Transplant Infect Dis"},{"issue":"4","key":"1761_CR34","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.infpip.2024.100419","volume":"6","author":"SC Schenidt Bispo Da Silva","year":"2024","unstructured":"Schenidt Bispo Da Silva SC, Fachi MM, Ricieri MC, De Ara\u00fajo Motta F. Pharmacist-led antimicrobial stewardship program in the treatment of Staphylococcus aureus bacteraemia in paediatric patients: a multivariate analysis. Infect Prev Pract. 2024;6(4):100419. https:\/\/doi.org\/10.1016\/j.infpip.2024.100419.","journal-title":"Infect Prev Pract"},{"issue":"1","key":"1761_CR35","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1017\/ash.2024.342","volume":"4","author":"TA Marins","year":"2024","unstructured":"Marins TA, De Jesus GR, Holubar M, et al. Evaluation of interventions led by pharmacists in antimicrobial stewardship programs in low- and middle-income countries: a systematic literature review. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e198. https:\/\/doi.org\/10.1017\/ash.2024.342.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"10","key":"1761_CR36","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/antibiotics11101336","volume":"11","author":"L Arteche-Eguizabal","year":"2022","unstructured":"Arteche-Eguizabal L, Corcuera-Mart\u00ednez De Tobillas I, Melgosa-Latorre F, et al. Multidisciplinary collaboration for the optimization of antibiotic prescription: analysis of clinical cases of pneumonia between emergency, internal medicine, and pharmacy services. Antibiotics. 2022;11(10):1336. https:\/\/doi.org\/10.3390\/antibiotics11101336.","journal-title":"Antibiotics"},{"issue":"05","key":"1761_CR37","doi-asserted-by":"publisher","first-page":"01","DOI":"10.31782\/IJCRR.2022.14515","volume":"14","author":"PK Manjhi","year":"2022","unstructured":"Manjhi PK. The five Ds for rational use of antimicrobial agents. Indian J Clin Exp Res. 2022;14(05):01\u20132. https:\/\/doi.org\/10.31782\/IJCRR.2022.14515.","journal-title":"Indian J Clin Exp Res"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-026-01761-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01761-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01761-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:39:47Z","timestamp":1787099987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-026-01761-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1186\/s13756-026-01761-4","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee of HC-FMUSP (approval number 6.234.289), and all patient data were anonymized prior to analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"109"}}